Latest filing published 07 Apr 2015 for MABVAX THERAPEUTICS HOLDINGS, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael M. Wick: trading record in brief
All filings by Michael M. Wick on record concern Mabvax Therapeutics Holdings, Inc. We count 107 filings; the first trade dates from 14 August 2006 and the latest from 4 April 2015.
Both buying and selling appear: 21 purchases worth €93k, against 79 sales worth €619k. Netting one side against the other leaves €526k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 6 option exercises.
Half of the purchases are above €246 and half below.
The record was last updated on 7 April 2015 with a share grant in Mabvax Therapeutics Holdings, Inc. The last insider purchase was made public on 17 June 2010, 5,988 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael M. Wick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001209191-15-032977:0
- 7,617 shares@ US$0.75Common StockSEC:0001222079-10-000003:0Canonical exit: 13 Sept 2010 (T+90)
- 200 shares@ US$0.7521Common StockSEC:0001222079-10-000003:1Canonical exit: 13 Sept 2010 (T+90)
- 500 shares@ US$0.7535Common StockSEC:0001222079-10-000003:2Canonical exit: 13 Sept 2010 (T+90)
- 400 shares@ US$0.7537Common StockSEC:0001222079-10-000003:3Canonical exit: 13 Sept 2010 (T+90)
- 1,600 shares@ US$0.7538Common StockSEC:0001222079-10-000003:4Canonical exit: 13 Sept 2010 (T+90)
- 100 shares@ US$0.7539Common StockSEC:0001222079-10-000003:5Canonical exit: 13 Sept 2010 (T+90)
- 8,300 shares@ US$0.754Common StockSEC:0001222079-10-000003:6Canonical exit: 13 Sept 2010 (T+90)
- 1,500 shares@ US$0.7542Common StockSEC:0001222079-10-000003:7Canonical exit: 13 Sept 2010 (T+90)
- 300 shares@ US$0.756Common StockSEC:0001222079-10-000003:8Canonical exit: 13 Sept 2010 (T+90)
- 200 shares@ US$0.757Common StockSEC:0001222079-10-000003:9Canonical exit: 13 Sept 2010 (T+90)
- 100 shares@ US$0.7574Common StockSEC:0001222079-10-000003:10Canonical exit: 13 Sept 2010 (T+90)
- 300 shares@ US$0.7577Common StockSEC:0001222079-10-000003:11Canonical exit: 13 Sept 2010 (T+90)
- 100 shares@ US$0.7578Common StockSEC:0001222079-10-000003:12Canonical exit: 13 Sept 2010 (T+90)
- 400 shares@ US$0.758Common StockSEC:0001222079-10-000003:13Canonical exit: 13 Sept 2010 (T+90)
- 1,300 shares@ US$0.7586Common StockSEC:0001222079-10-000003:14Canonical exit: 13 Sept 2010 (T+90)
- 200 shares@ US$0.759Common StockSEC:0001222079-10-000003:15Canonical exit: 13 Sept 2010 (T+90)
- 983 shares@ US$0.768Common StockSEC:0001222079-10-000003:16Canonical exit: 13 Sept 2010 (T+90)
- 1,100 shares@ US$0.7699Common StockSEC:0001222079-10-000003:17Canonical exit: 13 Sept 2010 (T+90)
- 200 shares@ US$0.77Common StockSEC:0001222079-10-000003:18Canonical exit: 13 Sept 2010 (T+90)
- 4,600 shares@ US$0.7543Common StockSEC:0001222079-10-000003:19Canonical exit: 13 Sept 2010 (T+90)
- 33,125 shares@ US$1.60Common StockSEC:0001222079-08-000010:0
- 21,875 shares@ US$1.60Common StockSEC:0001222079-08-000010:1
- 24,390 shares@ US$2.00Common StockSEC:0001222079-08-000010:2
- 100 shares@ US$2.04Common StockSEC:0001222079-08-000010:3
25 of 106 declarations